Research Summary
Analyzed using Evidence Intelligence™

Early meal timing improves nocturnal glucose levels.

Last updated September 9, 2026

Key finding

24 h component: -0.32 mmol l -1 min -1, t 102,232 = -188.9, p< 0.001

This study investigated the impact of early meal timing on glucose levels in pregnant individuals with gestational diabetes, finding lower nocturnal glucose levels in the early eating group.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study investigated the impact of early meal timing on glucose levels in pregnant individuals with gestational diabetes, finding lower nocturnal glucose levels in the early eating group.

Clinical relevance

These findings are important for managing gestational diabetes, as lower nocturnal glucose levels can reduce the risk of complications for both the mother and the baby. Adjusting meal timing could be a simple yet effective strategy for improving glycemic control in this population.

Keep in mind

The study's sample size may limit the generalizability of the findings. Potential confounding factors were not fully controlled for. The study only assessed short-term outcomes.

Published in

Journal Reference

Publication details and source links for this paper.

Hannah AC, Lucy W, Matthew PB, Amy MV. Early meal timing improves nocturnal glucose levels in pregnant individuals with gestational diabetes. Diabetologia. 2026;69(7):1839-1848. doi:10.1007/s00125-026-06701-w

Main Effects

The early eating group had lower nocturnal glucose levels (-0.32 mmol/l, p=0.001) compared to the late eating group.

The early eating group showed improved diurnal glucose patterns.

No significant difference in mean glucose levels (p=0.127) or percentage of time in range (p=0.384) between groups.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Continuous glucose monitoring and 2-hour plasma glucose, Change in diurnal mean glucose levels, Mean amplitude of glycemic excursions (MAGE), and 3 more.

Primary intervention

Continuous glucose monitoring

Primary outcomes

  • 2-hour plasma glucose
  • Change in diurnal mean glucose levels
  • Mean amplitude of glycemic excursions (MAGE)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
5
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 72

5

Related topics

6

Evidence pairs

997

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 5 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Insulin Delivery Systems and CGM Time in Range

Related evidence

Evidence relationship

Insulin Delivery Systems and Glucose Variability

Save evidence

Evidence relationship

Insulin Delivery Systems and Postprandial and OGTT Glucose

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

2-hour plasma glucose

Continuous glucose monitoring → 2-hour plasma glucose

Continuous glucose monitoring → 2-hour plasma glucose

Evidence Intelligence™
EvidenceScore™
78
Strong
ImpactScore™
83
Positive
ConsistencyScore™
67
generally_consistent
Supporting studies: Based on 3 studies
Add to Evidence Tracker

Change in diurnal mean glucose levels

Continuous glucose monitoring → Change in diurnal mean glucose levels

Continuous glucose monitoring → Change in diurnal mean glucose levels

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Mean amplitude of glycemic excursions (MAGE)

Continuous glucose monitoring → Mean amplitude of glycemic excursions (MAGE)

Continuous glucose monitoring → Mean amplitude of glycemic excursions (MAGE)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Nocturnal glucose control

Continuous glucose monitoring → Nocturnal glucose control

Continuous glucose monitoring → Nocturnal glucose control

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Pre-meal mean glucose

Continuous glucose monitoring → Pre-meal mean glucose

Continuous glucose monitoring → Pre-meal mean glucose

Evidence Intelligence™
EvidenceScore™
79
Strong
ImpactScore™
69
Positive
ConsistencyScore™
35
mixed
Supporting studies: Based on 4 studies
Add to Evidence Tracker

Time in range

Continuous glucose monitoring → Time in range

Continuous glucose monitoring → Time in range

Evidence Intelligence™
EvidenceScore™
85
Strong
ImpactScore™
77
Positive
ConsistencyScore™
62
generally_consistent
Supporting studies: Based on 13 studies
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Early meal timing resulted in a significant decrease in nocturnal glucose levels by 0.32 mmol/l.
  • No significant changes were observed in mean glucose levels (p=0.127).
  • Diurnal glucose patterns improved in the early eating group.
who this applies

Who this applies to

  • Pregnant individuals diagnosed with gestational diabetes.
  • Individuals seeking to manage glucose levels through dietary timing.
keep in mind

Keep in Mind

  • Results may not apply to all populations with diabetes.
  • The study did not explore long-term effects of meal timing.
  • Further research is needed to confirm findings and explore mechanisms.
between the lines

Between the Lines

  • The study's sample size may limit the generalizability of the findings.
  • Potential confounding factors were not fully controlled for.
  • The study only assessed short-term outcomes.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and CGM Time in Range, Insulin Delivery Systems and CGM Time in Range.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Delivery Systems improve CGM Time in Range?

Strong Evidence

Insulin Delivery Systems may improve CGM Time in Range.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    Time in range

    EvidenceScore™ Strong | EvidenceScore™ 85.2 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

  2. 2

    Pre-meal mean glucose

    EvidenceScore™ Strong | EvidenceScore™ 78.8 | moderate positive | ConsistencyScore™ Mixed | 1 study

  3. 3

    Nocturnal glucose control

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

35 supporting studies

Does Insulin Delivery Systems improve glucose variability?

Strong Evidence

Insulin Delivery Systems may improve glucose variability.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Mean amplitude of glycemic excursions (MAGE)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 8 supporting studies with generally consistent results and a positive effect signal.

8 supporting studies

Does Insulin Delivery Systems improve postprandial and ogtt glucose?

Strong Evidence

Insulin Delivery Systems may improve postprandial and ogtt glucose.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    2-hour plasma glucose

    EvidenceScore™ Strong | EvidenceScore™ 78.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

5 supporting studies

Does Continuous glucose monitoring improve change in diurnal mean glucose levels?

Emerging Evidence

Continuous glucose monitoring appears to improve change in diurnal mean glucose levels.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Change in diurnal mean glucose levels

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
1 supporting study
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.